secwatch.observer — SEC 8-K summary
======================================

Issuer:     Armata Pharmaceuticals, Inc. (ARMP)
CIK:        0000921114
Form:       8-K
Filed at:   2025-06-13T23:59:59+00:00
Accession:  0001104659-25-059346
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Armata Pharma annual meeting results: board elected, compensation approved, auditor ratified
--------------------------------------------------------------------------------

- Seven directors elected: Deborah L. Birx, Jules Haimovitz, Odysseas D. Kostas, Robin C. Kramer, Joseph M. Patti, Todd C. Peterson, Sarah Schlesinger — each for one-year term.
- Non-binding advisory vote on named executive officer compensation approved: 30,180,386 for, 75,804 against, 31,922 abstentions.
- Ratification of Ernst & Young as independent auditor for FY2025 approved: 31,471,009 for, 4,970 against, 2,147 abstain.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/921114/000110465925059346/0001104659-25-059346-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/921114/000110465925059346/tm2517977d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-059346

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer